American Vanguard Corporation (FRA:AVJ)

Market Cap	63.87M -39.5%
Revenue (ttm)	453.50M -1.0%
Net Income	-39.52M
EPS	-1.39
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.090
Previous Close	2.330
Day's Range	2.090 - 2.090
52-Week Range	1.740 - 5.270
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 6, 2026

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liq...

• Industry: Agricultural Chemicals
• Founded: 1969
• Employees: 739
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AVJ

Financial Performance

In 2025, American Vanguard's revenue was $515.11 million, a decrease of -5.88% compared to the previous year's $547.31 million. Losses were -$49.88 million, -60.52% less than in 2024.

Financial numbers in USD